ℹ️ Compiled from public regulatory records · Last regulator revision: October 20, 2025🚩 Report this page
Thymol
Active ingredient
Sold as FemiClear Infection…
US FDAGB MHRA
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Topical
- Markets covered
- 2
- Products on record
- 2
- FDA reports (12 mo)
- 8
Overview
Thymol is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | October 20, 2025 |
| GB United Kingdom | MHRA | 1 | November 8, 2019 |
USUnited States· FDA
1 product
Uses
This product is intended to help prevent bacterial vaginosis (BV) and yeast infections, and to moisturize.
How to take
GBUnited Kingdom· MHRA
1 product
Uses
As a gargle and mouthwash it is taken orally but not swallowed.
How to take
Sources & citations
- [1]FDA DailyMed · 018ed162-4b07-3d… · revised October 20, 2025 [PDF]
- [2]MHRA (UK) · PL183740021 · revised November 8, 2019
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.